Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis

Thorax

Volumn 64, Issue 11, 2009, Pages 926-931

  Wainwright, C E ^a,b   France, M W ^c   O'Rourke, P ^d   Anuj, S ^b,e   Kidd, T J ^b,e,f   Nissen, M D ^a,b,e,f   Sloots, T P ^b,e   Coulter, C ^c   Ristovski, Z ^g   Hargreaves, M ^g   Rose, B R ^h   Harbour, C ^h   Bell, S C ^b,c   Fennelly, K P ⁱ  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e Sir Albert Sakzewski Virus Research Centre   (Australia)

^f Pathology Queensland   (Australia)

^g QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACHROMOBACTER XYLOSOXIDANS; ADOLESCENT; ADULT; AEROSOL; AMBIENT AIR; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BURKHOLDERIA CENOCEPACIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; LUNG FIBROSIS; MALE; PARTICLE SIZE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SCHOOL CHILD; SPUTUM CULTURE; STENOTROPHOMONAS MALTOPHILIA;

EID: 72549116825     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.112466     Document Type: Article

References (35)

1. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry Annual Report 2000. Bethesda, MD: Cystic Fibrosis Foundation, 2001.
2. Rosenfeld M, Ramsey B, Gibson R. Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management. Curr Opin Pulm Med 2003;9:492-497 (Pubitemid 37268213)
3. Pitt T. Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa. Thorax 2002;57:921. (Pubitemid 35316265)
4. Ramsey B. To cohort or not to cohort: how transmissible is Pseudomonas aeruginosa? Am J Respir Crit Care Med 2002;166:906-907
5. Govan J, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996;60:539-574 (Pubitemid 26303478)
6. Armstrong D, Nixon G, Carzino R, et al. Detection of a widespread clone of Pseudomonas aeruginosa in a paediatric cystic fibrosis clinic. Am J Respir Crit Care Med 2002;166:983-987 (Pubitemid 35193230)
7. Jones A, Govan J, Doherty C, et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 2001;358:557-558 (Pubitemid 32772734)
8. Doring G, Jansen S, Noll H, et al. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward. Pediatr Pulmonol 1996;21:90-100. (Pubitemid 26098515)
9. Jones A, Govan J, Doherty C, et al. Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax 2003;58:525-527 (Pubitemid 36714016)
10. Panagea S, Winstanley C, Walshaw MJ, et al. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre and its survival on dry surfaces. J Hosp Infect 2005;59:102-107 (Pubitemid 40058035)
11. Saiman L, Siegal J. Infection control in cystic fibrosis. Clin Microbiol Rev 2004;17:57-71.
12. Siegel JD, Rhinehart E, Jackson M, et al. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007;35:S65-164. (Pubitemid 350213178)
13. Roy C, Milton D. Airborne transmission of communicable infection - the elusive pathway. N Engl J Med 2004;350:1710-1712 (Pubitemid 38501139)
14. Fennelly K, Martyny J, Fulton K, et al. Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness. Am J Respir Crit Care Med 2004;169:604-609 (Pubitemid 38270896)
15. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1994;152:1107-1136
16. De Vos D, Lim JRA, Pirnay J-P, et al. Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL. J Clin Microbiol 1997;35:1295-1299 (Pubitemid 27216783)
17. Segonds C, Heulin T, Marty N, et al. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates. J Clin Microbiol 1999;37:2201-2208 (Pubitemid 29277780)
18. Mahenthiralingam E, Bischof J, Byrne S, et al. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorens, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000;38:3165-3173 (Pubitemid 30693898)
19. Andersen A. New sampler for the collection, sizing and enumeration of viable airborne particles. J Bacteriol 1958;76:471-484
20. Macher J. Positive-hole correction of multiple-jet impactors for collecting viable microorganisms. Am Ind Hygiene J 1989;50:561-568 (Pubitemid 19269243)
21. Armstrong D, Grimwood K, Carlin J, et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997;156:1197-1204
22. Lee T, Brownlee K, Conway S, et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cystic Fibros 2003;2:29-34. (Pubitemid 36857407)
23. O'Carroll M, Syrmis M, Wainwright C, et al. Transmissible strains of P aeruginosa in paediatric and adult cystic fibrosis units. Eur Respir J 2004;24:101-106 (Pubitemid 39029075)
24. Riley E, Murphy G, Riley R. Airborne spread of measles in a suburban elementary school. Am J Epidemiol 1978;107:421-432 (Pubitemid 9003488)
25. Frankova V. Inhalatory infection of mice with influenza AO/PR8 virus. I. The site of primary virus replication and its spread in the respiratory tract. Acta Virol 1975;19:29-34.
26. Riley R, Mills C, O'Grady F, et al. Infectiousness of air from a tuberculosis ward. Am Rev Respir Dis 1962;85:511-525
27. Duguid J. The size and duration of air-carriage of respiratory droplets and dropletnuclei. J Hygiene (Lond) 1946;44:471-480
28. Loudon R, Roberts M. Relation between the airborne diameters of respiratory droplets and the diameter of the stains left after recovery. Nature 1967;213:95-96
29. Papineni R, Rosenthal F. The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 1997;10:105-116
30. Brimicombe RW, Dijkshoorn L, van der Reijden TJ, et al. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros 2008;7:30-36
31. Scott F, Pitt T. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients: implications for inpatient care of respiratory patients. J Clin Microbiol 2004;53:609-615
32. Sultan L, Nyka W, Mills C, et al. Tuberculosis disseminators. A study of the variability of aerial infectivity of tuberculous patients. Am Rev Respir Dis 1960;82:358-369
33. Li Y, Yu I, Xu P, et al. Predicting super-spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore. Am J Epidemiol 2004;160:719-728
34. Elkins M, Robinson M, Rose B, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006;354:229-240 (Pubitemid 43113028)
35. Clifton I, Fletcher L, Beggs C, et al. A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis. BMC Microbiol 2008;8:105 (Pubitemid 351951274)